Levy Tara Walpert
Known title: DirectorCIK: 0001583097
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Outback Steakhouse Focuses on Improving Beef Quality. Bloomin' Brands is highlighting efforts to enhance the quality of beef at Outback Steakhouse. This operational focus aims to strengthen the brand's core offering and competitive position. Recent comparisons with other restaurant stocks suggest investors are evaluating its value relative to peers.
Transaction History
| BRZE | ▲ Buy | Grant | 7,753 | $0 | 6/30/2026 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 19,746 | $0 | 4/22/2026 | View on chart |
| BRZE | ▼ Sell | Other | 62,562 | $0 | 1/30/2026 | View on chart |
| BRZE | ▲ Buy | Grant | 5,033 | $0 | 6/26/2025 | View on chart |
| BRZE | ▼ Sell | Other | 73,938 | $0 | 6/25/2025 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 5,881 | $0 | 4/23/2025 | View on chart |
| BRZE | ▲ Buy | Grant | 4,213 | $0 | 6/27/2024 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 6,508 | $0 | 4/23/2024 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 1,762 | $0 | 4/23/2024 | View on chart |
| BRZE | ▲ Buy | Grant | 5,846 | $0 | 6/29/2023 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 3,506 | $0 | 4/18/2023 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 1,762 | $0 | 4/18/2023 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 6,945 | $0 | 4/18/2023 | View on chart |
| BRZE | ▲ Buy | Grant | 5,210 | $0 | 6/30/2022 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 2,125 | $0 | 4/19/2022 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 3,506 | $0 | 4/19/2022 | View on chart |
| BLMN | ▲ Buy | Option Exercise | 1,762 | $0 | 4/19/2022 | View on chart |
| BRZE | ▼ Sell | Other | 62,562 | — | 11/19/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
Braze Shares Rise Amid Analyst Support and Valuation Focus
Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.
Braze Shares Rise Amid Analyst Support and Valuation Focus. Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.